Results
1 -
8 of
8
(Click
here to explore results)
- Small molecules targeting phosphoinositide 3-kinases. Peng Wu, Yongzhou Hu
, Med. Chem. Commun.
, 2012
, 3
, 1337
- The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov
, Chem. Sci.
, 2024
, 15
, 1003
- Recent biological applications of heterocyclic hybrids containing s-triazine scaffold. Muhammad Imran Ali, Muhammad Moazzam Naseer
, RSC Adv.
, 2023
, 13
, 30462
- Novel quinoline-derived mTOR inhibitors with remarkable enzymatic and cellular activities: design, synthesis and biological evaluation. Xiao-Dong Ma, Ni Qiu, Bo Yang, Qiao-Jun He, Yong-Zhou Hu
, Med. Chem. Commun.
, 2016
, 7
, 297
- Five and six membered heterocyclic rings endowed with azobenzene as dual EGFRT790M and VEGFR-2 inhibitors: design, synthesis, in silico ADMET profile, molecular docking, dynamic simulation and anticancer evaluations. Kurls E. Anwer, Sanadelaslam S. A. El-Hddad, Nour E. A. Abd El-Sattar, Ahmed El-morsy, Fathalla Khedr, Samy Mohamady, Doaa E. Keshek, Samir A. Salama, Khaled El-Adl, Noura S. Hanafy
, RSC Adv.
, 2023
, 13
, 35321
- An efficient synthesis of 2,4,7-trisubstituted pyrimido[1,2-a][1,3,5]triazin-6-ones. Nikhil Sachdeva, Anton V. Dolzhenko, Seow Joo Lim, Wee Ling Ong, Wai Keung Chui
, New J. Chem.
, 2015
, 39
, 4796
- CDK4/6 inhibitors: a brief overview and prospective research directions. Tenzin Adon, Dhivya Shanmugarajan, Honnavalli Yogish Kumar
, RSC Adv.
, 2021
, 11
, 29227
- 6,N
2-Diaryl-1,3,5-triazine-2,4-diamines: synthesis, antiproliferative activity and 3D-QSAR modeling. Ahmad Junaid, Felicia Phei Lin Lim, Lay Hong Chuah, Anton V. Dolzhenko
, RSC Adv.
, 2020
, 10
, 12135